| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |